A Case of Methotrexate-Associated Lymphoproliferative Disorder That Required to be Differentiated from Parotid Gland Cancer-Reference-Cited by-同舟云学术

A Case of Methotrexate-Associated Lymphoproliferative Disorder That Required to be Differentiated from Parotid Gland Cancer

Published:2022 Issue:4 Volume:115 Page:323-331
ISSN:0032-6313
Container-title:Practica Oto-Rhino-Laryngologica
language:en
Short-container-title:Pract.Otol.

Author:

Yonekura Syuji¹,Yamasaki Kazuki¹,Arai Ryo¹,Sonobe Yuri¹,Hanazawa Toyoyuki¹

Affiliation:

1. Graduate School of Medicine, Chiba University

Publisher

The Society of Practical Otolaryngology

Subject

Otorhinolaryngology

Link

https://www.jstage.jst.go.jp/article/jibirin/115/4/115_323/_pdf

Reference37 articles.

1. 1) 日本リウマチ学会：第3章　クリニカルクエスチョンと推奨　1．治療方針．関節リウマチ診療ガイドライン2020．16–21頁，診断と治療社，東京，2021．

2. 2) Salloum E, Cooper DL, Howe G, et al. : Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943–1949, 1996.

3. 3) Mariette X, Cazals-Hatem D, Warszawki J, et al. : Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909–3915, 2002.

4. 4) Hoshida Y, Xu JX, Fujita S, et al. : Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322–331, 2007.

5. 5) Takada H, Kaneko Y, Nakano K, et al. : Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study. Mod Rheumatol 32: 32–40, 2022.